No Detail Found!

Primary Drug Resistance to Anti-tuberculous Drugs in Karachi

Author(s)
Arshad Javaid Department of Pulmonology, Postgraduate Medical Institute, Peshawar.Pakistan
Nadim Rizvi Department of Pulmonoloyg, Postgraduate Medical Centre, Karachi. Pakistan
Mosavir Ansari Department of Pulmonology, Liaquat National Hospital, Karachi. Pakistan
Ashraf Sadiq Department of Chest Diseases and T.B, Ojha Institute of Chest Diseases, Karachi, Pakistan
Iqbal Sher Burki Department of Pulmonoloyg, Lyari General Hospital, Karachi, Pakistan
Nadeem Ur Rehman Department of Microbiology, The Aga Khan University Hospital, Karachi, Pakistan
Rumina Hasan Department of Microbiology, The Aga Khan University Hospital, Karachi, Pakistan
Afia Zafar Department of Microbiology, The Aga Khan University Hospital, Karachi, Pakistan
Abstract
Objective: To assess the frequency of primary drug resistance among newly diagnosed tuberculosis cases in Karachi. Study Design: Cross-sectional study. Place and Duration of Study: Multicentric study involving various TB clinics and treatment centres of Karachi between April to December 2005. Methodology: The frequency of drug resistance among new TB patients was evaluated using a non-probability convenient sampling methodology. Sputum sample was obtained from 140 newly diagnosed sputum smear-positive patients of pulmonary tuberculosis from various centres of Karachi. Sensitivities were performed by proportion method. Results: Fifteen (11.5%) samples in 130 eligible patients showed primary resistance to one or more drugs. Ten (7.6%) of the isolates tested were resistant to a single drug, none were resistant to 2 drugs, 4 (3.0%) to 3 drugs and 1 (0.76%) to 4 drugs while 1 (0.76%) to all 5 first line agents. Resistance to streptomycin (10 ug/ml) was seen in 8 (6.1%), isoniazid (1ug/ml) in 12 (9.2%), Rifampicin (5 ug/ml) in 4 (3.0%), ethambutol (10 ug/ml) in 1 (0.76%) and pyrazinamide in 6 (4.6%) samples. Primary Multi-Drug Resistance (PMDR) was found in 2 (1.5%) patients. (Isoniazid 1 ug/ml, rifampicin 5 ug/ml with or without other drugs). Conclusion: In the studied patients, primary drug resistance to at least one anti-tuberculosis drug was 11.5%. It requires an efficiently working anti-tuberculosis programme to prevent escalation including resistance.
Publication Details
Page(s) 699-702
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 18, Issue: 11, Year: 2008

Request the full text from PASTIC

Keywords
Primary drug resistance, Pulmonary tuberculosis (PTB), Mycobacterium tuberculosis (MTB)
0

Citations

0

Downloads

70

Views